News

Advisory board made up of leading digital and clinical research experts to guide company's scientific strategy.

AI-driven tool connects patients in need to clinical trials.

Clinical ink will participate on the SCRS Global Impact Board at an executive level and work closely with SCRS’ Leadership Council.

Wider use of cell-based immunotherapies demands new treatments for CRS and other complications.

Bezyl's mental health digital app now available to patients participating in clinical trials.

Collaboration will utilize THREAD's DCT technology.

Clinical Trial Navigator matches biopharma companies with independently-owned specialty physician practices to increase recruitment.

Collaboration combines Clario's eCOA innovations with Cogstate's experience in neuroscience research to yield high quality endpoints.

Partnership will launch new research sites in areas with highly diverse populations.

From the first trial on H.M.S. Salisbury to advancing towards a digital trials future.

Oracle extends technology first built to fight COVID-19 to accelerate efforts to get a safe and effective HIV vaccine to market.

New eConsent moves from early adopter to general availability, unifying with IRT technology.

Campaign to include creation of registry with updated HIV information.

Addition of clinical research site expands operations into Florida.

New guide provides comprehensive information on the types and phases of clinical trials, and how patients can participate.

VIDA has onboarded more than 1,000 sites globally in its network of imaging sites.

The latest business and people happenings all in one place.

Suite of retrospective data analysis services for clinical trial sponsors created in response to growing demand for precision data in lung treatment trials.

Merger forms a clinical research study start-up organization that focuses on trial initiation and study management administration.

Now available as a standalone cloud native clinical technology platform.

Clinical data cloud now includes statistical computing environment.

New enterprise solution to integrate how sites, sponsors, healthcare practitioners, and patients connect during clinical trial journey.

New big data analysis finds growing proportion of younger participating in breast cancer clinical trials, with implications for trial design and execution.

New collaboration with WHYZE Health to enable research through through healthcare.

App connects patients to local or hybrid trials.

Rebranding follows series of acquisitions and newly combined services in clinical development.

By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.